Open access
Aug 2026
High-Affinity Anti-nivolumab DNA Aptamer: A Novel Capture Reagent for Its Bioanalysis by an Enzyme-Linked Aptamer Assay.
This novel analytical method provides a sufficient quantitative range for the bioanalysis of nivolumab, thus offering a robust, specific, and cost-effective alternative for future pharmacokinetic studies.
Taisei Hojo, Nao Kobayashi, Chiho Hirayama et al.
· Chemical and pharmaceutical... · 1 citation